Product Code: GWW FDA class 1 21 CFR 882.1030

Ataxiagraph

Neurology

The Ataxiagraph is a neurological diagnostic device used to measure and record body sway and postural stability, providing an objective assessment of ataxia and balance disorders. It is classified as FDA Class 1, subject only to general controls and requiring no premarket notification; the exemption is limited to devices that do not provide an interpretation or clinical implication of the measurement. The product code is GWW, regulated under 21 CFR 882.1030 in the Neurology specialty. No special flags apply to this device.

510(k)s
0
FEI Numbers
4
Registration Numbers
4
Unique Applicants
0
Years Active

Research product code GWW in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
GWW
Device Class
FDA class 1
Regulation Number
882.1030
Medical Specialty
Neurology
Review Panel
NE
Submission Type
4

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

Exemption is limited to devices that do not provide an interpretation or a clinical implication of the measurement.

FEI Numbers

This FDA classification entry is associated with 4 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 4 registration numbers. Click on an entry to view related FDA registrations.